FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059459410> ?p ?o ?g. }

• W2059459410 endingPage "1743" @default.
• W2059459410 startingPage "1739" @default.
• W2059459410 abstract "With the availability of new, broad-spectrum antibiotics, initial therapy with a single agent has become an alternative to classic combinations in the management of febrile, neutropenic cancer patients. The aims of this study were to compare the efficacy of ceftazidime and imipenem as empirical monotherapy of febrile episodes in neutropenic patients, and to examine the frequency with which second-line antibiotics (amikacin, vancomycin, or both) were required. A prospective clinical trial was carried out in a single centre. Eligible patients with solid tumours or lymphoma were randomised to receive monotherapy with ceftazidime or imipenem. In the event of no response, amikacin and/or vancomycin were added in 48–72 h intervals (sequentially, or according to clinical or microbiological data). Efficacy was evaluable for 111 assessable episodes. Median neutrophil count at entry was 100 cells/μl and median duration of neutropenia was 4 days. Febrile episodes were classified as microbiologically (34%) or clinically documented (42%), and fever of unknown origin (24%). Gram-negative infections (57%) predominated over gram-positive isolates (30%). The overall success rate with monotherapy (69% versus 70%), or with modification (20% versus 23%) were equivalent for ceftazidime and imipenem (P = 0.75). The mortality in this series was 5%. Single-agent therapy with either ceftazidime or imipenem is effective for the empirical treatment of febrile episodes in neutropenic patients with solid tumours. Early addition of amikacin and/or vancomycin resolves most failures of the first step." @default.
• W2059459410 created "2016-06-24" @default.
• W2059459410 creator A5004936555 @default.
• W2059459410 creator A5018878514 @default.
• W2059459410 creator A5024026246 @default.
• W2059459410 creator A5026643961 @default.
• W2059459410 creator A5044300402 @default.
• W2059459410 creator A5048712117 @default.
• W2059459410 creator A5060170484 @default.
• W2059459410 creator A5069723692 @default.
• W2059459410 date "1996-09-01" @default.
• W2059459410 modified "2023-10-14" @default.
• W2059459410 title "Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients" @default.
• W2059459410 cites W1979759563 @default.
• W2059459410 cites W1991904626 @default.
• W2059459410 cites W2010169301 @default.
• W2059459410 cites W2011049226 @default.
• W2059459410 cites W2022252938 @default.
• W2059459410 cites W2028359382 @default.
• W2059459410 cites W2029987806 @default.
• W2059459410 cites W2043977100 @default.
• W2059459410 cites W2069178034 @default.
• W2059459410 cites W2079464706 @default.
• W2059459410 cites W2082902788 @default.
• W2059459410 cites W2100603233 @default.
• W2059459410 cites W2101760119 @default.
• W2059459410 cites W2102237290 @default.
• W2059459410 cites W2126519465 @default.
• W2059459410 cites W2126565263 @default.
• W2059459410 cites W2217407321 @default.
• W2059459410 cites W2331910443 @default.
• W2059459410 cites W2995475181 @default.
• W2059459410 cites W3022798003 @default.
• W2059459410 cites W4240011334 @default.
• W2059459410 doi "https://doi.org/10.1016/0959-8049(96)00188-8" @default.
• W2059459410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8983283" @default.
• W2059459410 hasPublicationYear "1996" @default.
• W2059459410 type Work @default.
• W2059459410 sameAs 2059459410 @default.
• W2059459410 citedByCount "21" @default.
• W2059459410 countsByYear W20594594102013 @default.
• W2059459410 countsByYear W20594594102016 @default.
• W2059459410 countsByYear W20594594102018 @default.
• W2059459410 countsByYear W20594594102020 @default.
• W2059459410 countsByYear W20594594102021 @default.
• W2059459410 crossrefType "journal-article" @default.
• W2059459410 hasAuthorship W2059459410A5004936555 @default.
• W2059459410 hasAuthorship W2059459410A5018878514 @default.
• W2059459410 hasAuthorship W2059459410A5024026246 @default.
• W2059459410 hasAuthorship W2059459410A5026643961 @default.
• W2059459410 hasAuthorship W2059459410A5044300402 @default.
• W2059459410 hasAuthorship W2059459410A5048712117 @default.
• W2059459410 hasAuthorship W2059459410A5060170484 @default.
• W2059459410 hasAuthorship W2059459410A5069723692 @default.
• W2059459410 hasConcept C126322002 @default.
• W2059459410 hasConcept C141071460 @default.
• W2059459410 hasConcept C2776694085 @default.
• W2059459410 hasConcept C2776968632 @default.
• W2059459410 hasConcept C2777063308 @default.
• W2059459410 hasConcept C2777427914 @default.
• W2059459410 hasConcept C2777637488 @default.
• W2059459410 hasConcept C2778850193 @default.
• W2059459410 hasConcept C2778980435 @default.
• W2059459410 hasConcept C2779489039 @default.
• W2059459410 hasConcept C2779631663 @default.
• W2059459410 hasConcept C501593827 @default.
• W2059459410 hasConcept C523546767 @default.
• W2059459410 hasConcept C54355233 @default.
• W2059459410 hasConcept C71924100 @default.
• W2059459410 hasConcept C86803240 @default.
• W2059459410 hasConcept C89423630 @default.
• W2059459410 hasConcept C94665300 @default.
• W2059459410 hasConceptScore W2059459410C126322002 @default.
• W2059459410 hasConceptScore W2059459410C141071460 @default.
• W2059459410 hasConceptScore W2059459410C2776694085 @default.
• W2059459410 hasConceptScore W2059459410C2776968632 @default.
• W2059459410 hasConceptScore W2059459410C2777063308 @default.
• W2059459410 hasConceptScore W2059459410C2777427914 @default.
• W2059459410 hasConceptScore W2059459410C2777637488 @default.
• W2059459410 hasConceptScore W2059459410C2778850193 @default.
• W2059459410 hasConceptScore W2059459410C2778980435 @default.
• W2059459410 hasConceptScore W2059459410C2779489039 @default.
• W2059459410 hasConceptScore W2059459410C2779631663 @default.
• W2059459410 hasConceptScore W2059459410C501593827 @default.
• W2059459410 hasConceptScore W2059459410C523546767 @default.
• W2059459410 hasConceptScore W2059459410C54355233 @default.
• W2059459410 hasConceptScore W2059459410C71924100 @default.
• W2059459410 hasConceptScore W2059459410C86803240 @default.
• W2059459410 hasConceptScore W2059459410C89423630 @default.
• W2059459410 hasConceptScore W2059459410C94665300 @default.
• W2059459410 hasIssue "10" @default.
• W2059459410 hasLocation W20594594101 @default.
• W2059459410 hasLocation W20594594102 @default.
• W2059459410 hasOpenAccess W2059459410 @default.
• W2059459410 hasPrimaryLocation W20594594101 @default.
• W2059459410 hasRelatedWork W1968594847 @default.
• W2059459410 hasRelatedWork W1993698692 @default.
• W2059459410 hasRelatedWork W2005848532 @default.

• next